Thomas K Equels insider trades: AIM ImmunoTech (AIM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
55 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | AIM | ↑ Buy | 20,299 | $0.16 | $3K | Direct | Nov 6, 2026 (0d) |
| Oct 23, 2026 | AIM | ↑ Buy | 31,675 | $0.16 | $5K | Direct | Oct 26, 2026 (3d) |
| Oct 22, 2026 | AIM | ↑ Buy | 31,250 | $0.16 | $5K | Direct | Oct 23, 2026 (1d) |
| Sep 17, 2026 | AIM | ↑ Buy | 24,000 | $0.21 | $5K | Direct | Sep 18, 2026 (1d) |
| Sep 16, 2026 | AIM | ↑ Buy | 11,000 | $0.21 | $2K | Direct | Sep 17, 2026 (1d) |
| Sep 15, 2026 | AIM | ↑ Buy | 22,000 | $0.22 | $5K | Direct | Sep 16, 2026 (1d) |
| Sep 14, 2026 | AIM | ↑ Buy | 5,900 | $0.22 | $1K | Direct | Sep 15, 2026 (1d) |
| Jun 13, 2025 | AIM | ↑ Buy | 107 | $7.70 | $824 | Direct | Jun 16, 2025 (3d) |
| Jun 12, 2025 | AIM | ↑ Buy | 103 | $8.70 | $896 | Direct | Jun 13, 2025 (1d) |
| Apr 11, 2025 | AIM | ↑ Buy | 1,968,504 | $0.03 | $50K | Direct | Apr 23, 2025 (12d) |
| Apr 4, 2025 | AIM | ↑ Buy | 41,000 | $0.06 | $3K | Direct | Apr 7, 2025 (3d) |
| Mar 5, 2025 | AIM | ↑ Buy | 50,000 | $0.13 | $7K | Direct | Mar 6, 2025 (1d) |
| Mar 4, 2025 | AIM | ↑ Buy | 44,000 | $0.12 | $5K | Direct | Mar 5, 2025 (1d) |
| Mar 4, 2025 | AIM | ↑ Buy | 83,334 | $0.12 | $10K | Direct | Mar 4, 2025 (0d) |
| Dec 18, 2024 | AIM | ↑ Buy | 22,727 | $0.21 | $5K | Direct | Dec 19, 2024 (1d) |
| Nov 21, 2024 | AIM | ↑ Buy | 20,000 | $0.21 | $4K | Direct | Jan 21, 2025 (61d) |
| Nov 20, 2024 | AIM | ↑ Buy | 85,000 | $0.20 | $17K | Direct | Nov 21, 2024 (1d) |
| Nov 20, 2024 | AIM | ↑ Buy | 60,110 | $0.18 | $11K | Direct | Nov 20, 2024 (0d) |
| Sep 16, 2024 | AIM | ↑ Buy | 5,000 | $0.30 | $2K | Direct | Sep 17, 2024 (1d) |
| Sep 13, 2024 | AIM | ↑ Buy | 20,000 | $0.31 | $6K | Direct | Sep 16, 2024 (3d) |
| May 6, 2024 | AIM | ↑ Buy | 61,729 | $0.41 | $25K | Direct | May 7, 2024 (1d) |
| Mar 15, 2024 | AIM | ↑ Buy | 75,758 | $0.33 | $25K | Direct | Mar 18, 2024 (3d) |
| Nov 27, 2023 | AIM | ↑ Buy | 33,861 | $0.44 | $15K | Direct | Nov 27, 2023 (0d) |
| Sep 29, 2023 | AIM | ↑ Buy | 22,676 | $0.44 | $10K | Direct | Sep 29, 2023 (0d) |
| Aug 25, 2023 | AIM | ↑ Buy | 8,222 | $0.67 | $6K | Direct | Aug 25, 2023 (0d) |
| Aug 24, 2023 | AIM | ↑ Buy | 14,993 | $0.67 | $10K | Direct | Aug 24, 2023 (0d) |
| Jul 17, 2023 | AIM | ↑ Buy | 16,950 | $0.59 | $10K | Direct | Jul 17, 2023 (0d) |
| Jan 3, 2023 | AIM | ↑ Buy | 161,291 | $0.31 | $50K | Direct | Jan 4, 2023 (1d) |
| Jul 16, 2021 | AIM | ↑ Buy | 15,625 | $1.92 | $30K | Direct | Jul 16, 2021 (0d) |
| Feb 24, 2021 | AIM | ↑ Buy | 11,062 | $2.26 | $25K | Direct | Feb 24, 2021 (0d) |
| Dec 17, 2020 | AIM | ↑ Buy | 14,535 | $1.72 | $25K | Direct | Dec 17, 2020 (0d) |
| Sep 3, 2020 | AIM | ↑ Buy | 12,316 | $2.03 | $25K | Direct | Sep 3, 2020 (0d) |
| Aug 21, 2020 | AIM | ↑ Buy | 10,730 | $2.33 | $25K | Direct | Aug 21, 2020 (0d) |
| Jun 27, 2019 | HEB | ↑ Buy | 2,632 | $4.37 | $12K | Direct | Jun 27, 2019 (0d) |
| Jun 21, 2019 | HEB | ↑ Buy | 29,404 | $4.03 | $118K | Direct | Jun 21, 2019 (0d) |
| Mar 19, 2019 | HEB | ↑ Buy | 13,400 | $0.18 | $2K | Direct | Mar 19, 2019 (0d) |
| Nov 30, 2018 | HEB | ↑ Buy | 20,000 | $0.19 | $4K | Direct | Dec 3, 2018 (3d) |
| Oct 26, 2018 | HEB | ↑ Buy | 3,500 | $0.20 | $711 | Direct | Oct 29, 2018 (3d) |
| Oct 25, 2018 | HEB | ↑ Buy | 100,000 | $0.20 | $20K | Direct | Oct 25, 2018 (0d) |
| Jul 27, 2018 | HEB | ↑ Buy | 34,483 | $0.29 | $10K | Direct | Jul 27, 2018 (0d) |
| Jul 23, 2018 | HEB | ↑ Buy | 112,904 | $0.31 | $35K | Direct | Jul 23, 2018 (0d) |
| Apr 27, 2018 | HEB | ↑ Buy | 32,000 | $0.32 | $10K | Direct | Apr 30, 2018 (3d) |
| Apr 27, 2017 | HEB | ↑ Buy | 72,464 | $0.69 | $50K | Direct | Apr 27, 2017 (0d) |
| Apr 11, 2017 | HEB | ↑ Buy | 200,000 | $0.50 | $100K | Direct | Apr 11, 2017 (0d) |
| Dec 22, 2016 | HEB | ↑ Buy | 68,493 | $0.73 | $50K | Direct | Dec 23, 2016 (1d) |
| Nov 1, 2016 | HEB | ↑ Buy | 10,000 | $1.00 | $10K | Direct | Nov 1, 2016 (0d) |
| Jul 8, 2016 | HEB | ↑ Buy | 48,000 | $0.12 | $6K | Direct | Jul 8, 2016 (0d) |
| Jul 1, 2016 | HEB | ↑ Buy | 171,000 | $0.12 | $20K | Direct | Jul 1, 2016 (0d) |
| Mar 18, 2016 | HEB | ↑ Buy | 30,000 | $0.13 | $4K | Direct | Mar 21, 2016 (3d) |
| Mar 11, 2016 | HEB | ↑ Buy | 40,000 | $0.16 | $6K | Direct | Mar 14, 2016 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas K Equels's insider trades
Thomas K Equels is CEO & President at AIM ImmunoTech (AIM). Since Apr 15, 2015, Thomas has reported 55 open-market purchases worth $976K and no sales on SEC Form 4. In the last 12 months: 7 buys ($27K).
Their filings also include grants and awards (40 filings), other transactions (12 filings), conversions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AIM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.